BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 33892983)

  • 1. Microplanning verification and 2017/2018 measles vaccination campaign in Nigeria: Lessons learnt.
    Hamisu M; Dieng B; Taiwo L; Jean Baptiste AE; Bawa S; Wagai J; Ibizugbe S; Braka F; Nsubuga P; Shuaib F; Oteri J
    Vaccine; 2021 Nov; 39 Suppl 3():C46-C53. PubMed ID: 33892983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the Geographic Information System (GIS) in immunisation service delivery; its use in the 2017/2018 measles vaccination campaign in Nigeria.
    Oteri J; Idi Hussaini M; Bawa S; Ibizugbe S; Lambo K; Mogekwu F; Wiwa O; Seaman V; Kolbe-Booysen O; Braka F; Nsubuga P; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C29-C37. PubMed ID: 33478790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internal displacement; an impediment to the successful implementation of planned measles supplemental activities in Nigeria, a case study of Benue State.
    Korave J; Bawa S; Ageda B; Ucho A; Bem-Bura DM; Onimisi A; Dieng B; Nsubuga P; Oteri J; Fiona B; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C76-C81. PubMed ID: 33461836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using data to improve outcomes of supplemental immunisation activities: 2017/2018 Nigeria measles vaccination campaign.
    Mogekwu FI; Oteri JA; Nsubuga P; Ezebilo O; Maxwell N; Wiwa O; Braka F; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C38-C45. PubMed ID: 33461831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative study of the development and utilization of health facility-based immunization microplans in Uganda.
    Mafigiri DK; Iradukunda C; Atumanya C; Odie M; Mancuso A; Tran N; McGrath J; Luzze H
    Health Res Policy Syst; 2021 Aug; 19(Suppl 2):52. PubMed ID: 34380523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Planning for supplemental immunization activities using the readiness assessment dashboard: Experience from 2017/2018 Measles vaccination campaign, Nigeria.
    Terna Richard M; Taiwo L; Jean Baptiste AE; Bawa S; Dieng B; Wiwa O; Lambo K; Braka F; Shuaib F; Oteri J
    Vaccine; 2021 Nov; 39 Suppl 3():C21-C28. PubMed ID: 34247903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nigeria experience on the use of polio assets for the 2017/18 measles vaccination campaign follow-up.
    Oteri AJ; Adamu U; Dieng B; Bawa S; Terna N; Nsubuga P; Owoaje ET; Kassogue M; Jean Baptiste AE; Braka F; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C3-C11. PubMed ID: 33962837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
    Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leveraging on the 2017/2018 measles vaccination campaign to improve health workers knowledge and practice on injection safety: A case study of north-central states, Nigeria.
    Okoronkwo C; Taiwo LA; Asolo JA; Jean Baptiste AE; Wagai J; Nsubuga P; Braka F; Shuaib F; Oteri J
    Vaccine; 2021 Nov; 39 Suppl 3():C54-C59. PubMed ID: 34024661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of an Intervention to Use a Measles, Rubella, and Polio Mass Vaccination Campaign to Strengthen Routine Immunization Services in Nepal.
    Wallace AS; Bohara R; Stewart S; Subedi G; Anand A; Burnett E; Giri J; Shrestha J; Gurau S; Dixit S; Rajbhandari R; Schluter WW
    J Infect Dis; 2017 Jul; 216(suppl_1):S280-S286. PubMed ID: 28838201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis.
    Zimmermann M; Frey K; Hagedorn B; Oteri AJ; Yahya A; Hamisu M; Mogekwu F; Shuaib F; McCarthy KA; Chabot-Couture G
    Vaccine; 2019 Sep; 37(41):6039-6047. PubMed ID: 31471147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles resurgence following a nationwide measles vaccination campaign in Nigeria, 2005-2008.
    Weldegebriel GG; Gasasira A; Harvey P; Masresha B; Goodson JL; Pate MA; Abanida E; Chevez A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S226-31. PubMed ID: 21666165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ensuring accountability in implementation of supplementary immunisation activities: A case study of the 2017/2018 measles vaccination campaign in Nigeria.
    Momoh J; Oteri AJ; Mogekwu F; Onwu N; Dieng B; Bawa S; Braka F; Nsubuga P; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C12-C20. PubMed ID: 33714654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The challenges of insecurity on implementing vaccination campaign and its effect on measles elimination and control efforts: A case study of 2017/18 measles campaign in Borno state, Nigeria.
    Babakura B; Nomhwange T; Jean Baptiste AE; Dede O; Taiwo L; Abba S; Soyemi M; Idowu AM; Terna Richard M; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C66-C75. PubMed ID: 33546886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost-effectiveness analysis of traditional and geographic information system-supported microplanning approaches for routine immunization program management in northern Nigeria.
    Ali D; Levin A; Abdulkarim M; Tijjani U; Ahmed B; Namalam F; Oyewole F; Dougherty L
    Vaccine; 2020 Feb; 38(6):1408-1415. PubMed ID: 31924428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving polio vaccination coverage in Nigeria through the use of geographic information system technology.
    Barau I; Zubairu M; Mwanza MN; Seaman VY
    J Infect Dis; 2014 Nov; 210 Suppl 1():S102-10. PubMed ID: 25316823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria.
    Wagai JN; Rhoda D; Prier M; Trimmer MK; Clary CB; Oteri J; Okposen B; Adeniran A; Danovaro-Holliday C; Cutts F
    PLoS One; 2021; 16(2):e0247415. PubMed ID: 33635913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of WhatsApp group messaging in the coordination of measles supplemental immunization activity in Cross Rivers State, Nigeria, 2018.
    Masresha B; Nwankwo O; Bawa S; Igbu T; Oteri J; Tafida H; Braka F
    Pan Afr Med J; 2020; 35(Suppl 1):6. PubMed ID: 32373257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential for improving routine immunisation waste management using measles vaccination campaign 2017 in Kebbi State, Nigeria.
    Oteri J; Bawa S; Christopher E; Nsubuga P; Dieng B; Braka F; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C60-C65. PubMed ID: 33451781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
    Portnoy A; Jit M; Helleringer S; Verguet S
    Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.